company background image
A039860 logo

NanoEntek KOSDAQ:A039860 Stock Report

Last Price

₩3.03k

Market Cap

₩97.1b

7D

-6.1%

1Y

-35.2%

Updated

07 Sep, 2024

Data

Company Financials

NanoEntek, Inc.

KOSDAQ:A039860 Stock Report

Market Cap: ₩97.1b

A039860 Stock Overview

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

About the company

A039860 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

Earnings have declined by 33.2% per year over past 5 years
Highly volatile share price over the past 3 months
Shareholders have been diluted in the past year
Does not have a meaningful market cap (₩97B)

NanoEntek, Inc. Competitors

P&K Skin Research Center

KOSDAQ:A347740

₩68.8b

ADM Korea

KOSDAQ:A187660

₩63.4b

Biotoxtech

KOSDAQ:A086040

₩70.3b

C&R Research

KOSDAQ:A359090

₩63.7b

Price History & Performance

Summary of all time highs, changes and price drops for NanoEntek
Historical stock prices
Current Share Price₩3,025.00
52 Week High₩5,810.00
52 Week Low₩2,705.00
Beta0.73
11 Month Change-17.46%
3 Month Change-9.70%
1 Year Change-35.22%
33 Year Change-63.77%
5 Year Change-32.93%
Change since IPO-32.63%

Recent News & Updates

NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

Aug 06
NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Mar 21
NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Recent updates

NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

Aug 06
NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Mar 21
NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 14
Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Jan 26
If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

Jan 04
Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 14
NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Shareholder Returns

A039860KR Life SciencesKR Market
7D-6.1%-2.7%-5.4%
1Y-35.2%32.8%-3.8%

Return vs Industry: A039860 underperformed the KR Life Sciences industry which returned 32.8% over the past year.

Return vs Market: A039860 underperformed the KR Market which returned -3.8% over the past year.

Price Volatility

Is A039860's price volatile compared to industry and market?
A039860 volatility
A039860 Average Weekly Movement12.6%
Life Sciences Industry Average Movement9.5%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market3.5%

Stable Share Price: A039860's share price has been volatile over the past 3 months.

Volatility Over Time: A039860's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1987130Jin-Hyung Parkwww.nanoentek.com

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 1987 and is headquartered in Seoul, South Korea.

NanoEntek, Inc. Fundamentals Summary

How do NanoEntek's earnings and revenue compare to its market cap?
A039860 fundamental statistics
Market cap₩97.13b
Earnings (TTM)-₩473.12m
Revenue (TTM)₩27.80b

3.5x

P/S Ratio

-205.3x

P/E Ratio

Is A039860 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A039860 income statement (TTM)
Revenue₩27.80b
Cost of Revenue₩14.26b
Gross Profit₩13.54b
Other Expenses₩14.02b
Earnings-₩473.12m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-14.73
Gross Margin48.71%
Net Profit Margin-1.70%
Debt/Equity Ratio0%

How did A039860 perform over the long term?

See historical performance and comparison